Live tape
Top 8, mentions 7d10,063TSLA2,067 mentions▲ +0.05GOOGL1,608 mentions▲ +0.04NVDA1,230 mentions▲ +0.07CRWV1,216 mentions▲ +0.03SPCX1,103 mentions▲ +0.07QQQ1,074 mentions▲ +0.04META891 mentions▲ +0.05NBIS874 mentions▲ +0.06

Equity · Healthcare

ACAD

NASDAQ

ACADIA Pharmaceuticals Inc.

$19.14 −2.79% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Oct 16, 2026
Price · Chart
63 sessions
$35 $15 21 Jul 16 Oct

The line runs $25.43 on 21 July through $19.14 on 16 October, on a scale from $15 to $35. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView TradingView chart · our licensed closes: 63 sessions, 21 Jul – 16 Oct 2026
Market cap $3.3B
P/E (TTM) 8.6
52-week range $18.62 – $30.58
Avg volume 140.4K

as of Oct 16, 2026

ACAD insider trades

SEC Form 4 · last 90 days · newest reported trade 6 Aug 2026
Open-market buys 0
Open-market sells 3
Net sold $1.02M
Non-trade filings 3
Date Insider Type Shares Value
06 Aug 2026 Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER Sell 14,292 $418K
05 Aug 2026 Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER Sell 5,849 $170K
30 Jul 2026 Thompson Elizabeth H.Z. EVP, Head of Research & Dev Sell 16,558 $433K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
06 Aug 2026 Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER Option exercise 14,292 $255K
05 Aug 2026 Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER Option exercise 5,849 $104K
29 Jul 2026 Thompson Elizabeth H.Z. EVP, Head of Research & Dev Option exercise 32,272

ACAD reported financials

SEC EDGAR XBRL SEC EDGAR

ACAD reported revenue of $1.1B for the fiscal year ended 31 Dec 2025. Net income over the same period was $391.0M.

Figure Reported Period
Revenue $1.1B 31 Dec 2025 fiscal year
Net income $391.0M 31 Dec 2025 fiscal year
Diluted EPS $2.30 31 Dec 2025 fiscal year
Total assets $1.7B 30 Jun 2026 at period end
Total equity $1.3B 30 Jun 2026 at period end

ACAD earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $0.18 —
31 Mar 2026 Q1 2026 $0.02 —
31 Dec 2025 FY 2025 $2.30 —
30 Sep 2025 Q3 2025 $0.42 —
30 Jun 2025 Q2 2025 $0.16 —
31 Mar 2025 Q1 2025 $0.11 —
31 Dec 2024 FY 2024 $1.36 —
30 Sep 2024 Q3 2024 $0.20 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

ACAD institutional holders

SEC Form 13F SEC EDGAR

13 of the 45 institutional funds we track reported a ACAD position for the quarter ended 30 Jun 2026 — a combined $1.4B; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Baker Bros. Advisors Held (±25%) +0.0% shares 42,912,904 $1.1B
Point72 Asset Management Held (±25%) −5.6% shares 2,433,168 $61.6M
Citadel Advisors Added +250.4% shares 2,182,177 $55.2M
Marshall Wace Added +2,216.5% shares 1,764,838 $44.7M
D. E. Shaw & Co. Added +132.6% shares 1,697,937 $43.0M
Renaissance Technologies Trimmed −25.6% shares 1,282,596 $32.4M
Two Sigma Investments Held (±25%) +19.6% shares 926,992 $23.5M
Fisher Asset Management Held (±25%) −4.6% shares 699,230 $17.7M
Millennium Management Held (±25%) −16.4% shares 589,924 $14.9M
AQR Capital Management Held (±25%) −1.0% shares 522,749 $13.2M

Showing the 10 largest of 13 reported positions. The figures above count all of them.

ACAD fails-to-deliver

SEC CNS data SEC

On 24 Sep 2026, 6,765 shares of ACAD failed to deliver (about $172K).

Settlement date Shares failed Notional % of shares out
24 Sep 2026 6,765 $172K 0.004%
04 Sep 2026 1,281 $36K 0.001%

Congressional trades in ACAD

STOCK Act disclosures House disclosures

The most recent congressional trade disclosed in ACAD is a sale by Sara Jacobs (house, CA), dated 16 Jun 2022.

Date Member Type Amount
16 Jun 2022 filed 28 Jul 2022 Sara Jacobs house · Democrat–CA Sale $1K–$15K

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
  4. SEC EDGARSEC EDGAR 13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. House disclosuresU.S. House of Representatives financial disclosures
  7. SEC EDGARValuation computed from SEC EDGAR filings